Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2025

TCT 766: Protamine At Reduced Dose For TAVR Anticoagulation Reversal

Presenter: Mohammed Ebrahim

October 27, 2025

Presentation TCT 2025

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

Presenter: Mehmet Cilingiroglu

October 27, 2025

Presentation TCT 2025

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Presenter: Devi G. Nair

October 27, 2025

Presentation TCT 2025

In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation??

Presenter: Suhail Dohad

October 27, 2025

Presentation TCT 2025

TCT 998: Dual Antiplatelet Therapy (DAT) versus Triple Therapy (TAT) post Percutaneous Coronary Intervention (PCI) in patients requiring Chronic Anticoagulation: Meta-analysis.

Presenter: Kanishk Aggarwal

October 27, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

Randomized Controlled Trial of Mechanical Thrombectomy with Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Results from STORM-PE

Presenter: Robert A. Lookstein

October 26, 2025

Presentation TCT 2025

TCT 1929: A Case of Trombectomy in Pulmonary Embolism With Absolute Contraindication to Anticoagulation

Presenter: Mario Iannaccone

October 26, 2025

Presentation TCT 2025

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Presenter: Grant William Reed

October 25, 2025

Presentation TCT 2025

TCT 1369: When Watchman Isn’t Watched Enough: Rare Persistent Late Device Thrombus Despite Anticoagulation

Presenter: Ammer Aldairi

October 25, 2025

Presentation NY Valves 2025

Management of HALT After TAVR: Anticoagulation, Which Agent, How Long

Presenter: George D. Dangas

June 26, 2025

Advertisement

TCT 766: Protamine At Reduced Dose For TAVR Anticoagulation Reversal

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation??

TCT 998: Dual Antiplatelet Therapy (DAT) versus Triple Therapy (TAT) post Percutaneous Coronary Intervention (PCI) in patients requiring Chronic Anticoagulation: Meta-analysis.

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Randomized Controlled Trial of Mechanical Thrombectomy with Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Results from STORM-PE

TCT 1929: A Case of Trombectomy in Pulmonary Embolism With Absolute Contraindication to Anticoagulation

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

TCT 1369: When Watchman Isn’t Watched Enough: Rare Persistent Late Device Thrombus Despite Anticoagulation

Management of HALT After TAVR: Anticoagulation, Which Agent, How Long

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content